Melanoma, a portable, painless device identifies it without biopsies
A small, fast and highly accurate device detects melanoma with the same sensitivity as hospital diagnostics. It can be the turning point for routine visits.
A small, fast and highly accurate device detects melanoma with the same sensitivity as hospital diagnostics. It can be the turning point for routine visits.
Synthetic biology can literally transform the reality we know. Like any transformative technology it can make us jump forward, or into the void.
A single nanoparticle works in two ways: it increases the effectiveness of chemotherapy and acts as an immune system stimulant.
A research team has developed a new type of diagnostic tool that can quickly identify relapses of leukemia
It's the eve of a strong easing of restrictions: the Spanish flu has something to teach us, however. History recommends caution.
It has a protein base (like Novavax) and is already guaranteed to be effective. The "open source" vaccine will take its first steps in India from February.
Is it possible to beat cancer? BioNTech begins phase 2 clinical trial for cancer vaccine, hoping for positive results
There are many open questions about Omicron, the new variant of SARS-CoV-2 detected in South Africa. Here's what we know so far.
A new generation vaccine based on T lymphocytes and distributed in patches has obtained the ok to start with clinical studies at the beginning of the new year
Human trials of the preventative vaccine against the deadliest breast cancer are finally ready to start: here are the next steps.
New sequencing technology accelerates the development of rapid and effective treatments against COVID-19 and its variants. An "ultra-potent" antibody isolated.
Oil demand will rise by 5,4 million barrels a day this year and by another 3,1 million barrels next year, the IEA says.
The flu vaccine, which has achieved great results in the preclinical phase, begins its first tests on humans. If it works, it will eliminate the annual vaccination
In a video call with investors, Moderna warns of new waves coming for Covid-19
From the "return to normality" we ended up directly in the "new life". Let's move forward, let's update the plans: this is my "feeling" for the next few months.
Fighting the infection that causes Covid-19 is not just a matter of vaccines. Research has identified genes responsible for the infection, and is working to derive therapeutic options
An "Achilles heel" of brain cancer led to a vaccine tested by mice in 2019. Today, phase 1 has also started in humans.
We eat something that is harmless to others and we fill ourselves with bubbles (or worse reactions). Food allergies are a plague - this is how we are fighting them.
Medicago and GSK have announced the start of phase 3 trials for their plant-based Covid vaccine.
The voracious demand for gasoline has stopped due to Covid. And an IEA report says what many suspected: it will never return to previous levels.
MIT's ultrasound tests in the range used for human diagnostics are yielding good results on COVID-19. It opens the way for new research.